Professional Documents
Culture Documents
BY : F JENIT (29Y/F)
HIGH 160-189
VERY HIGH >190
TRIGLYCERIDES (mg/dl)
NORMAL <150
HIGH 200-499
:
T7646467
Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
Page : 3 of 15
NAME REF. : F JENIT (29Y/F)
BY : DR SREEKUMAR
TEST : PALEO PROFILE - BASIC
ASKED
SAMPLE COLLECTED AT :
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL, KANYA
KUMARI, TAMIL NADU- 629001 - 629001
PATIENTID
: FJ17234729
TEST NAME TECHNOLOGY VALUE UNITS
ALKALINE PHOSPHATASE PHOTOMETRY 54.4 U/L
BILIRUBIN - TOTAL PHOTOMETRY 0.64 mg/dl
BILIRUBIN -DIRECT PHOTOMETRY 0.2 mg/dl
BILIRUBIN (INDIRECT) CALCULATED 0.44 mg/dl
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 13 U/l
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 18.7 U/l
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.2 U/l
PROTEIN - TOTAL PHOTOMETRY 7.25 gm/dl
ALBUMIN - SERUM PHOTOMETRY 4.5 gm/dl
SERUM GLOBULIN PHOTOMETRY 2.75 gm/dL
SERUM ALB/GLOBULIN RATIO CALCULATED 1.64 Ratio
Please correlate with clinical conditions.
NORMAL RANGE
45 - 129
0.3-1.2
< 0.3
0-0.9
< 38
< 31
< 34
5.7-8.2
3.2-4.8
2.5-3.4
0.9 - 2
Method :
ALKP - MODIFIED IFCC METHOD BILT - VANADATE OXIDATION BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES GGT - MODIFIED IFCC METHOD
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION PR
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT) SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VAL
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
Sample Collected on (SCT) : 14 Jul 2021 10:00
Sample Received on (SRT) : 15 Jul 2021 23:23
Report Released on (RRT) :
16 Jul 2021 07:16
Sample Type : SERUM
Labcode Barcode 1507018046/TAM95
:
:
T7646467
Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
Page : 4 of 15
NAME REF. : F JENIT (29Y/F)
BY : DR SREEKUMAR
TEST ASKED : PALEO PROFILE - BASIC
SAMPLE COLLECTED AT :
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL,
KANYA KUMARI, TAMIL NADU- 629001
- 629001
PATIENTID
: FJ17234729
TEST NAME TECHNOLO VAL
MAGNESIUM GY
PHOTOMETR UE
2.08
Reference Range :- Y
Clinical significance:
UNITS
mg/dL
Magnesium is the fourth most abundant cation in the body and second most prevalent intracellular cation. The total body magnesium cont
approximately 1 mol, of which 55% reside in the skeleton. About 45% of the magnesium is intracellular. In general higher the metabolic a
is its magnesium content. Magnesium is a cofactor for more than 300 enzymes in the body.
Disorders of magnesium metabolism are separated into those causing hypomagnesaemia/magnesium deficiencies and hypermagnesemia
common in patient in hospitals. Moderate to severe deficiency of magnesium is usually due to loss of magnesium from the gastrointestina
One of the more serious complications of magnesium deficiency is cardiac arrhythmia. Symptomatic hypermagnsemia is almost always ca
intake, resulting from administration of antacids, enemas, and parenteral fluids containing magnesium. Depression of neuromuscular sys
manifestation of magnesium intoxication.
External quality control program participation:
College Of American Pathologists: Chemistry survey; CAP Number: 7193855-01
Please correlate with clinical conditions.
Method:- MODIFIED XYLIDYL BLUE REACTION METHOD
Sample Collected on (SCT) :
14 Jul 2021 10:00
Sample Received on (SRT) 15 Jul 2021 23:23
:
Report Released on (RRT) : 16 Jul 2021 07:16
Sample Type SERUM
Labcode :
Barcode :
1507018046/TAM95
:
T7646467
Dr.Prachi Sinkar MD(Path)
Dr.Caesar Sengupta MD(Micro)
Page : 5 of 15
NAME REF. BY :
F JENIT (29Y/F)
TEST ASKED :
DR SREEKUMAR
:
PALEO PROFILE - BASIC
SAMPLE COLLECTED AT :
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL, KANYA
KUMARI, TAMIL NADU- 629001 - 629001
PATIENTID :
FJ17234729
TEST NAME
TECHNOLOGY VALUE UNITS REFERENCE RANGE
THYROID STIMULATING HORMONE (TSH) C.L.I.A
3.58
µIU/ml
0.3-5.5
Comments : ***
Please correlate with clinical conditions. Method :
TSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY
Pregnancy reference ranges for TSH 1st Trimester : 0.10 - 2.50
2nd Trimester : 0.20 - 3.00
3rd Trimester : 0.30 - 3.00
Reference:
Guidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpar
1-46
Sample Collected on (SCT) :
14 Jul 2021 10:00
Sample Received on (SRT) : 15 Jul 2021 23:23
:
T7646467
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703
Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
Page : 7 of 15
NAME REF. : F JENIT (29Y/F)
BY : DR SREEKUMAR
TEST ASKED : PALEO PROFILE - BASIC
SAMPLE COLLECTED AT :
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL,
KANYA KUMARI, TAMIL NADU- 629001
- 629001
PATIENTID
: FJ17234729
TEST NAME TECHNOLO VAL
EST. GLOMERULAR FILTRATION RATE (eGFR) GY
CALCULATE UE
126
Reference Range :- D
UNITS
mL/min/1.73 m2
> = 90 : Normal 60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease 30 - 44 : Moderate to Severe Decrease 15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate kidne
from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate glomerular filtration rate (eGFR), a “go
measurement for assessment of renal function, and report the value when serum creatinine is measured for patients 18 and older, when a
It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of ki
Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and manage
CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.
Please correlate with clinical conditions. Method:- CKD-EPI Creatinine Equation
Sample Collected on (SCT) :
14 Jul 2021 10:00
Sample Received on (SRT) 15 Jul 2021 23:23
:
Report Released on (RRT) : 16 Jul 2021 07:16
Sample Type SERUM
Labcode :
Barcode :
1507018046/TAM95
:
T7646467
Dr.Prachi Sinkar MD(Path)
Dr.Caesar Sengupta MD(Micro)
Page : 8 of 15
NAME REF. BY : F JENIT (29Y/F)
1.003-1.030
Negative
5-8
Negative
<=0.2
Negative
Negative
Pale Yellow
Clear
Negative
Negative
2-3
Absent
Absent
Absent
* To Obtain Counts in Cells / HPF Divide the Cells / ul by 5 Please correlate with clinical conditions.
Method : Manual Dipstick Method
Sample Collected on (SCT)
Sample Received on (SRT)
Report Released on (RRT)
:
14 Jul 2021 10:00
: 15 Jul 2021 22:52
:
16 Jul 2021 05:01
Sample Type :
URINE
Labcode
:
1507091273/TAM95
Dr.Prachi Sinkar MD(Path)
Dr.Caesar Sengupta MD(Micro)
Barcode :
T6553649
Page : 10 of 15
NAME REF. BY : F JENIT (29Y/F)
: HbA1c,HEMOGRAM
SAMPLE COLLECTED AT :
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL,
KANYA KUMARI, TAMIL NADU- 629001 - 629001
PATIENTID
:
FJ17234729
TEST NAME TECHNOLOGY VALUE
UNITS
HbA1c - (HPLC - NGSP Certified)
H.P.L.C
Reference Range :
4.8 %
Guidance For Known Diabetics
BY : DR SREEKUMAR
TEST : HbA1c,HEMOGRAM
ASKED
SAMPLE COLLECTED AT :
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL,
KANYA KUMARI, TAMIL NADU- 629001 - 629001
PATIENTID :
FJ17234729
TEST NAME VALUE UNITS
TOTAL LEUCOCYTES COUNT 4.59 X 10³ / µL
NEUTROPHILS 63.5 %
LYMPHOCYTE PERCENTAGE 30.1 %
MONOCYTES 2.6 %
EOSINOPHILS 3.3 %
BASOPHILS 0.2 %
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 %
NEUTROPHILS - ABSOLUTE COUNT 2.91 X 10³ / µL
LYMPHOCYTES - ABSOLUTE COUNT 1.38 X 10³ / µL
MONOCYTES - ABSOLUTE COUNT 0.12 X 10³ / µL
BASOPHILS - ABSOLUTE COUNT 0.01 X 10³ / µL
EOSINOPHILS - ABSOLUTE COUNT 0.15 X 10³ / µL
IMMATURE GRANULOCYTES(IG) 0.01 X 10³ / µL
TOTAL RBC 6.17 X 10^6/µL
NUCLEATED RED BLOOD CELLS NUCLEATED RED BLOOD CELLS Nil Nil X 10³ / µL
% %
Labcode :
EDTA
Barcode :
1507091617/TAM95
:
T9221269
Dr.Prachi Sinkar MD(Path)
Dr.Caesar Sengupta MD(Micro) Page
: 12 of 15
NAME REF. : F JENIT (29Y/F)
BY : DR SREEKUMAR
TEST ASKED : BLOOD SUGAR (F)
SAMPLE COLLECTED AT :
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL,
KANYA KUMARI, TAMIL NADU- 629001
- 629001
PATIENTID
:
FJ17234729
TEST NAME TECHNOLOGY
VALU
UNITS
E
FASTING BLOOD SUGAR PHOTOMETRY
Reference Range :-
70-99
Please correlate with clinical conditions. Method:- GOD-PAP METHOD
~~ End of report ~~
63 mg/dL
Sample Collected on (SCT) :
14 Jul 2021 10:00
Sample Received on (SRT) 15 Jul 2021 22:52
:
Report Released on (RRT) : 16 Jul 2021 10:08
Sample Type FLUORIDE
Labcode :
Barcode :
1507091297/TAM95
:
V1502877
Dr.Prachi Sinkar MD(Path)
Dr.Caesar Sengupta MD(Micro)
Page : 13 of 15
CUSTOMER DETAILS
Barcodes/Sample_Type :
Labcode :
Ref By :
Sample_Type/Tests :
EDTA:HBA , HEMOGRAM - 6 PART (DIFF)
FLUORIDE:FBS
SERUM:PALEO PROFILE - BASIC
Sample Collected At :
KUMARI, TAMIL NADU- 629001 - 629001
Sample Collected on (SCT) :
Report Released on (RRT) :
Amount Collected :
Rs.2400/-(two thousand four hundred only)
Age: 29Y
Sex: F
1507091273,1507091617,1507091297,1507018046
DR SREEKUMAR
URINE:UALB , COMPLETE URINE ANALYSIS
EDTA:HBA , HEMOGRAM - 6 PART (DIFF)
FLUORIDE:FBS
SERUM:PALEO PROFILE - BASIC
24 B, CELINE ARCADE, DISTILLERY ROAD, NAGERCOIL, KANYA
KUMARI, TAMIL NADU- 629001 - 629001
14 Jul 2021 10:00
16 Jul 2021 10:08
:
Rs.2400/-(two thousand four hundred only)
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies should
interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that may
be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950851,8450950852,8450950853,8450950854 between 10:00 to 18:00
only.
named or identified.
eters from time to time for the same
nfirmed.
es and limitations of technologies should